567 related articles for article (PubMed ID: 30577797)
1. Recent updates in cancer immunotherapy: a comprehensive review and perspective of the 2018 China Cancer Immunotherapy Workshop in Beijing.
Li Z; Song W; Rubinstein M; Liu D
J Hematol Oncol; 2018 Dec; 11(1):142. PubMed ID: 30577797
[TBL] [Abstract][Full Text] [Related]
2. Next-generation immuno-oncology agents: current momentum shifts in cancer immunotherapy.
Pan C; Liu H; Robins E; Song W; Liu D; Li Z; Zheng L
J Hematol Oncol; 2020 Apr; 13(1):29. PubMed ID: 32245497
[TBL] [Abstract][Full Text] [Related]
3. Combination strategies to maximize the benefits of cancer immunotherapy.
Zhu S; Zhang T; Zheng L; Liu H; Song W; Liu D; Li Z; Pan CX
J Hematol Oncol; 2021 Sep; 14(1):156. PubMed ID: 34579759
[TBL] [Abstract][Full Text] [Related]
4. Novel strategies for immuno-oncology breakthroughs with cell therapy.
Liu H; Pan C; Song W; Liu D; Li Z; Zheng L
Biomark Res; 2021 Jul; 9(1):62. PubMed ID: 34332618
[TBL] [Abstract][Full Text] [Related]
5. Immune checkpoint inhibitors win the 2018 Nobel Prize.
Huang PW; Chang JW
Biomed J; 2019 Oct; 42(5):299-306. PubMed ID: 31783990
[TBL] [Abstract][Full Text] [Related]
6. From a Patient Advocate's Perspective: Does Cancer Immunotherapy Represent a Paradigm Shift?
Madden DL
Curr Oncol Rep; 2018 Feb; 20(1):8. PubMed ID: 29411148
[TBL] [Abstract][Full Text] [Related]
7. CAR T Cell Therapy Progress and Challenges for Solid Tumors.
Stern LA; Jonsson VD; Priceman SJ
Cancer Treat Res; 2020; 180():297-326. PubMed ID: 32215875
[TBL] [Abstract][Full Text] [Related]
8. PD-1, PD-L1 (B7-H1) and Tumor-Site Immune Modulation Therapy: The Historical Perspective.
Wang J; Yuan R; Song W; Sun J; Liu D; Li Z
J Hematol Oncol; 2017 Jan; 10(1):34. PubMed ID: 28122590
[TBL] [Abstract][Full Text] [Related]
9. [Cancer immunotherapy crowned with Nobel Prize in Physiology or Medicine awarded to James Allison and Tasuku Honjo].
Teillaud JL
Med Sci (Paris); 2019 Apr; 35(4):365-366. PubMed ID: 31038115
[No Abstract] [Full Text] [Related]
10. Understanding and overcoming the resistance of cancer to PD-1/PD-L1 blockade.
Shergold AL; Millar R; Nibbs RJB
Pharmacol Res; 2019 Jul; 145():104258. PubMed ID: 31063806
[TBL] [Abstract][Full Text] [Related]
11. Nobel committee honors tumor immunologists.
Rotte A; D'Orazi G; Bhandaru M
J Exp Clin Cancer Res; 2018 Oct; 37(1):262. PubMed ID: 30376854
[TBL] [Abstract][Full Text] [Related]
12. Immunotherapy in breast cancer.
Bayraktar S; Batoo S; Okuno S; Glück S
J Carcinog; 2019; 18():2. PubMed ID: 31160888
[TBL] [Abstract][Full Text] [Related]
13. Personalized Immuno-Oncology.
Jain KK
Med Princ Pract; 2021; 30(1):1-16. PubMed ID: 32841942
[TBL] [Abstract][Full Text] [Related]
14. [From the time in the wilderness to the Nobel Prize in Physiology or Medicine awarded to James Allison and Tasuku Honjo: the Long March of cancer immunotherapy].
Fridman WH; Teillaud JL
Med Sci (Paris); 2019 Apr; 35(4):367-373. PubMed ID: 31038116
[No Abstract] [Full Text] [Related]
15. A Nobel Prize-worthy pursuit: cancer immunology and harnessing immunity to tumour neoantigens.
Altmann DM
Immunology; 2018 Nov; 155(3):283-284. PubMed ID: 30320408
[TBL] [Abstract][Full Text] [Related]
16. Systems glycobiology for discovering drug targets, biomarkers, and rational designs for glyco-immunotherapy.
Chiang AWT; Baghdassarian HM; Kellman BP; Bao B; Sorrentino JT; Liang C; Kuo CC; Masson HO; Lewis NE
J Biomed Sci; 2021 Jun; 28(1):50. PubMed ID: 34158025
[TBL] [Abstract][Full Text] [Related]
17. [Immune checkpoint inhibitors. A breakthrough in cancer therapy].
Cárdenas-Oyarzo AM; Bocchieri-Oyarce PA; Méndez-Laport CR; Zolezzi JM; Ríos JA
Rev Med Chil; 2022 Jan; 150(1):93-99. PubMed ID: 35856970
[TBL] [Abstract][Full Text] [Related]
18. Translation of cancer immunotherapy from the bench to the bedside.
Guo Q; Huang F; Goncalves C; Del Rincón SV; Miller WH
Adv Cancer Res; 2019; 143():1-62. PubMed ID: 31202357
[TBL] [Abstract][Full Text] [Related]
19. Refining Immuno-Oncology Approaches in Metastatic Prostate Cancer: Transcending Current Limitations.
Wong RL; Yu EY
Curr Treat Options Oncol; 2021 Jan; 22(2):13. PubMed ID: 33433743
[TBL] [Abstract][Full Text] [Related]
20. Putting the Immunologic Brakes on Cancer.
Wolchok J
Cell; 2018 Nov; 175(6):1452-1454. PubMed ID: 30500529
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
